us en false false Default
Skip directly to Accessibility Notice
PPH VanEck Pharmaceutical ETF Please read important disclosure Close important disclosure false

PPH
VanEck Pharmaceutical ETF

PPH
VanEck Pharmaceutical ETF

  • NAV
    $100.97

    as of December 17, 2025
  • YTD RETURNS
    19.01%

    as of December 17, 2025
  • Total Net Assets
    $1.14B

    as of December 17, 2025
  • Total Expense Ratio
    0.36%
  • Inception Date
    12/20/2011

About PPH

VanEck Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Buy Now
Let's Connect
Subscribe

Overview

Why PPH

  • Highly Liquid Companies: Tracks the largest most liquid pharmaceutical companies
  • Industry Leaders: Favors established industry leaders with meaningful scale
  • Global Scope: Provides exposure to U.S. and international equities for global industry representation  

Performance

Performance History:

Average Annual Total Returns* (%)

View All ETFs View All Indices
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 10.84 15.85 20.88 16.29 12.21 11.62 6.75 9.99
PPH (Share Price) 10.77 15.82 20.88 16.26 12.25 11.62 6.73 10.07
MVPPHTR (Index) 10.83 15.87 20.50 15.80 11.73 11.23 6.52 9.80
Performance Differential (NAV - Index) 0.01 -0.02 0.38 0.49 0.48 0.39 0.23 0.19
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 1.63 3.39 6.05 -2.88 12.60 9.85 5.68 9.08
PPH (Share Price) 1.67 3.44 6.11 -2.77 12.61 9.82 5.68 9.16
MVPPHTR (Index) 1.65 3.37 5.71 -3.33 12.10 9.46 5.45 8.89
Performance Differential (NAV - Index) -0.02 0.02 0.34 0.45 0.50 0.39 0.23 0.19

*Returns less than one year are not annualized.

The performance data quoted represents past performance. Past performance is not a guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Please call 800.826.2333 or visit vaneck.com for performance current to the most recent month ended.

Prices as of 12/17/2025

NAV/
Market
Price 		Volume
30-Day Avg./
Last Trading Day 		Daily Change
NAV/
Last Price 		YTD Change NAV/
Last Price 		Premium/
Discount 		30-Day
Median
Bid Ask
Spread 		NAV
Chart
PPH $100.97
$101.00 		440,487
288,231 		$-0.56 / -0.55%
$-0.52 / -0.51% 		+19.01%
+19.10% 		$0.03
0.03% 		0.02%

Fees

Holdings

Daily Holdings (%) as of 12/17/2025

Download XLS Get holdings
Total Holdings: 26
Ticker
 Holding Name % of Net
Assets
Identifier (FIGI)
Shares
 Asset Class Market Value
(US$) 		Notional Value
LLY US
 Eli Lilly & Co 24.26
BBG000BNBDC2
275,944
 Stock 287,475,700 --
NVS US
 Novartis Ag 9.14
BBG000LYF3S8
801,916
 Stock 108,282,717 --
MRK US
 Merck & Co Inc 7.84
BBG000BPD168
936,740
 Stock 92,905,873 --
NVO US
 Novo Nordisk A/S 5.94
BBG000BQBKR3
1,473,033
 Stock 70,366,786 --
GSK US
 Gsk Plc 4.75
BBG000BLB481
1,156,814
 Stock 56,348,410 --
JNJ US
 Johnson & Johnson 4.73
BBG000BMHYD1
266,516
 Stock 56,056,310 --
MCK US
 Mckesson Corp 4.52
BBG000DYGNW7
66,372
 Stock 53,530,345 --
BMY US
 Bristol-Myers Squibb Co 4.49
BBG000DQLV23
993,732
 Stock 53,214,349 --
PFE US
 Pfizer Inc 4.48
BBG000BR2B91
2,118,782
 Stock 53,054,301 --
AZN US
 Astrazeneca Plc 4.40
BBG000BZ0DK8
579,784
 Stock 52,099,390 --
ABBV US
 Abbvie Inc 4.19
BBG0025Y4RY4
221,390
 Stock 49,659,991 --
SNY US
 Sanofi Sa/France 4.04
BBG000BBD5N1
993,510
 Stock 47,827,571 --
COR US
 Cencora Inc 3.61
BBG000MDCQC2
124,737
 Stock 42,779,802 --
ZTS US
 Zoetis Inc 3.23
BBG0039320N9
313,528
 Stock 38,328,798 --
HLN US
 Haleon Plc 2.84
BBG018GZNCH6
3,425,817
 Stock 33,641,523 --
TEVA US
 Teva Pharmaceutical Industries Ltd 2.35
BBG000C0CD58
927,604
 Stock 27,883,776 --
TAK US
 Takeda Pharmaceutical Co Ltd 2.30
BBG000LF8708
1,881,921
 Stock 27,231,397 --
VTRS US
 Viatris Inc 0.62
BBG00Y4RQNH4
628,675
 Stock 7,355,498 --
JAZZ US
 Jazz Pharmaceuticals Plc 0.59
BBG000G9CGL0
42,745
 Stock 7,049,292 --
ELAN US
 Elanco Animal Health Inc 0.43
BBG00LJYS1P8
229,013
 Stock 5,056,607 --
CORT US
 Corcept Therapeutics Inc 0.37
BBG000BKJG33
53,131
 Stock 4,371,619 --
AXSM US
 Axsome Therapeutics Inc 0.35
BBG00B6G7GL7
27,763
 Stock 4,108,924 --
BHC US
 Bausch Health Cos Inc 0.12
BBG000DLFM21
215,714
 Stock 1,471,169 --
OGN US
 Organon & Co 0.10
BBG00ZQRGW24
171,861
 Stock 1,201,308 --
PRGO US
 Perrigo Co Plc 0.08
BBG000CNFQW6
70,621
 Stock 943,497 --
-USD CASH-
 0.08
--
936,680
 Cash Bal 936,680 --
--
Other/Cash 0.17
--
0
 Cash 1,960,878 --
← Scroll for more information →
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Portfolio

Sector Weightings (%) as at 11/30/2025

  • Sector

    % of Net Assets

  • Health Care

    99.84

  • Other/Cash

    0.16

Country Weightings (%) as at 11/30/2025

  • Country

    % of Net Assets

  • United States

    64.82

  • United Kingdom

    11.85

  • Switzerland

    8.69

  • Denmark

    6.04

  • France

    4.12

  • Japan

    2.25

  • Israel

    2.07

  • Other/Cash

    0.16

Distributions

Yields  as of  12/17/2025

Distribution Frequency

Quarterly

30-Day SEC Yield

1.86%

Distribution Yield

1.56%

12 Month Yield

1.92%

Yield information reflects temporary waivers of expenses and/or fees. Yields would have been reduced had these fees/expenses been included. In the absence of temporary expense waivers or reimbursements, the 30-Day SEC Yield for VanEck Pharmaceutical ETF would have been 1.86% on 12/17/25. Distributions may vary from time to time.

Team

Literature

PPH